{"transactions":[{"id":1005429,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2025-11-07T16:57:25.000Z","date":"2025-11-05","kind":"grant","planned":false,"acquired":true,"shares":21216,"price":6.8,"value":144268.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2025, February 5, 2026, May 5, 2026 and August 5, 2026, respectively."}],"balance_after":21216,"derivative":{"exercise_price":6.8,"expiration_date":"2035-11-05","underlying":"Common Stock","underlying_shares":21216},"source":{"system":"sec-edgar","filing":"0001628280-25-050514","document":"wk-form4_1762534641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828025050514/wk-form4_1762534641.xml","form_type":"4"}},{"id":1362819,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2024-11-18T16:47:41.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":21880,"price":4.64,"value":101523.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively."}],"balance_after":21880,"derivative":{"exercise_price":4.64,"expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":21880},"source":{"system":"sec-edgar","filing":"0001628280-24-048211","document":"wk-form4_1731948454.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828024048211/wk-form4_1731948454.xml","form_type":"4"}},{"id":1702102,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-12-21T22:56:08.000Z","date":"2023-12-20","kind":"grant","planned":false,"acquired":true,"shares":20450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest in one year from the date of the grant, beginning on December 20, 2023, subject to the non-employee director's continued service on the Board of Directors."}],"balance_after":20450,"derivative":{"exercise_price":0.45,"expiration_date":"2033-12-19","underlying":"Common Stock","underlying_shares":20450},"source":{"system":"sec-edgar","filing":"0001493152-23-045777","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000149315223045777/ownership.xml","form_type":"4"}},{"id":1748201,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-11-07T16:57:48.000Z","date":"2023-11-03","kind":"grant","planned":false,"acquired":true,"shares":15495,"price":5.51,"value":85377.45,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively."}],"balance_after":15495,"derivative":{"exercise_price":5.51,"expiration_date":"2033-11-03","underlying":"Common Stock","underlying_shares":15495},"source":{"system":"sec-edgar","filing":"0001628280-23-037248","document":"wk-form4_1699376259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023037248/wk-form4_1699376259.xml","form_type":"4"}},{"id":1804746,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2023-08-17T16:05:50.000Z","date":"2022-11-01","kind":"grant","planned":false,"acquired":true,"shares":11480,"price":7,"value":80360.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 1, 2022,  February 1, 2023, May 1, 2023 and August 1, 2023, respectively."}],"balance_after":11480,"derivative":{"exercise_price":7,"expiration_date":"2032-11-01","underlying":"Common Stock","underlying_shares":11480},"source":{"system":"sec-edgar","filing":"0001628280-23-029776","document":"wf-form4_169228834017538.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828023029776/wf-form4_169228834017538.xml","form_type":"4"}},{"id":2048530,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-24T02:00:31.000Z","date":"2023-01-19","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated October 18, 2022, by and among Ayala Pharmaceuticals, Inc. (\"Ayala\"), Advaxis, Inc. (\"Advaxis\"), and DOE Merger Sub, Inc., a wholly owned subsidiary of Advaxis (the \"Merger Agreement\"). The acquisition is more fully described in Ayala's definitive proxy statement filed with the Securities and Exchange Commission on December 12, 2022. In accordance with the terms of the Merger Agreement, each share of Ayala's common stock (the \"Ayala Common Stock\"), was cancelled and converted into the right to receive 0.1874 shares (the \"Exchange Ratio\") of Advaxis common stock (the \"Advaxis Common Stock\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each outstanding option to purchase Ayala Common Stock (each an \"Ayala Option\") was substituted and converted automatically into an option (each, an \"Advaxis Replacement Option\") to purchase the number of shares of Advaxis Common Stock equal to the product obtained by multiplying (a) the number of shares of Ayala Common Stock subject to such Ayala Option immediately prior to the effective time of the merger, by (b) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share, with each such Advaxis Replacement Option to have an exercise price per share of Advaxis Common Stock equal to (x) the per share exercise price for the shares of Ayala Common Stock subject to the corresponding Ayala Option immediately prior to the effective time of the merger, divided by (y) the Exchange Ratio, rounded up to the nearest whole cent. The term, exercisability and other provisions of each Advaxis Replacement Option generally remains the same as the corresponding Ayala Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each outstanding option to purchase Ayala Common Stock (each an \"Ayala Option\") was substituted and converted automatically into an option (each, an \"Advaxis Replacement Option\") to purchase the number of shares of Advaxis Common Stock equal to the product obtained by multiplying (a) the number of shares of Ayala Common Stock subject to such Ayala Option immediately prior to the effective time of the merger, by (b) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share, with each such Advaxis Replacement Option to have an exercise price per share of Advaxis Common Stock equal to (x) the per share exercise price for the shares of Ayala Common Stock subject to the corresponding Ayala Option immediately prior to the effective time of the merger, divided by (y) the Exchange Ratio, rounded up to the nearest whole cent. The term, exercisability and other provisions of each Advaxis Replacement Option generally remains the same as the corresponding Ayala Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests and becomes exercisable on the earlier of (i) June 13, 2023 or (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":1.63,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001213900-23-004541","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000121390023004541/ownership.xml","form_type":"4"}},{"id":2048529,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-24T02:00:31.000Z","date":"2023-01-19","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated October 18, 2022, by and among Ayala Pharmaceuticals, Inc. (\"Ayala\"), Advaxis, Inc. (\"Advaxis\"), and DOE Merger Sub, Inc., a wholly owned subsidiary of Advaxis (the \"Merger Agreement\"). The acquisition is more fully described in Ayala's definitive proxy statement filed with the Securities and Exchange Commission on December 12, 2022. In accordance with the terms of the Merger Agreement, each share of Ayala's common stock (the \"Ayala Common Stock\"), was cancelled and converted into the right to receive 0.1874 shares (the \"Exchange Ratio\") of Advaxis common stock (the \"Advaxis Common Stock\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each outstanding option to purchase Ayala Common Stock (each an \"Ayala Option\") was substituted and converted automatically into an option (each, an \"Advaxis Replacement Option\") to purchase the number of shares of Advaxis Common Stock equal to the product obtained by multiplying (a) the number of shares of Ayala Common Stock subject to such Ayala Option immediately prior to the effective time of the merger, by (b) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share, with each such Advaxis Replacement Option to have an exercise price per share of Advaxis Common Stock equal to (x) the per share exercise price for the shares of Ayala Common Stock subject to the corresponding Ayala Option immediately prior to the effective time of the merger, divided by (y) the Exchange Ratio, rounded up to the nearest whole cent. The term, exercisability and other provisions of each Advaxis Replacement Option generally remains the same as the corresponding Ayala Option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each outstanding option to purchase Ayala Common Stock (each an \"Ayala Option\") was substituted and converted automatically into an option (each, an \"Advaxis Replacement Option\") to purchase the number of shares of Advaxis Common Stock equal to the product obtained by multiplying (a) the number of shares of Ayala Common Stock subject to such Ayala Option immediately prior to the effective time of the merger, by (b) the Exchange Ratio, with any fractional shares rounded down to the nearest whole share, with each such Advaxis Replacement Option to have an exercise price per share of Advaxis Common Stock equal to (x) the per share exercise price for the shares of Ayala Common Stock subject to the corresponding Ayala Option immediately prior to the effective time of the merger, divided by (y) the Exchange Ratio, rounded up to the nearest whole cent. The term, exercisability and other provisions of each Advaxis Replacement Option generally remains the same as the corresponding Ayala Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":10.35,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001213900-23-004541","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000121390023004541/ownership.xml","form_type":"4"}},{"id":2048528,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-24T02:00:31.000Z","date":"2023-01-19","kind":"disposition_to_issuer","acquired":false,"shares":250,"ownership":{"direct":false,"nature":"Held by Reporting Person's son"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated October 18, 2022, by and among Ayala Pharmaceuticals, Inc. (\"Ayala\"), Advaxis, Inc. (\"Advaxis\"), and DOE Merger Sub, Inc., a wholly owned subsidiary of Advaxis (the \"Merger Agreement\"). The acquisition is more fully described in Ayala's definitive proxy statement filed with the Securities and Exchange Commission on December 12, 2022. In accordance with the terms of the Merger Agreement, each share of Ayala's common stock (the \"Ayala Common Stock\"), was cancelled and converted into the right to receive 0.1874 shares (the \"Exchange Ratio\") of Advaxis common stock (the \"Advaxis Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated October 18, 2022, by and among Ayala Pharmaceuticals, Inc. (\"Ayala\"), Advaxis, Inc. (\"Advaxis\"), and DOE Merger Sub, Inc., a wholly owned subsidiary of Advaxis (the \"Merger Agreement\"). The acquisition is more fully described in Ayala's definitive proxy statement filed with the Securities and Exchange Commission on December 12, 2022. In accordance with the terms of the Merger Agreement, each share of Ayala's common stock (the \"Ayala Common Stock\"), was cancelled and converted into the right to receive 0.1874 shares (the \"Exchange Ratio\") of Advaxis common stock (the \"Advaxis Common Stock\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001213900-23-004541","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000121390023004541/ownership.xml","form_type":"4"}},{"id":2048878,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-01-23T18:19:33.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":2342,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Received in the Merger in exchange for an employee stock option to acquire 12,500 shares of the common stock of Old Ayala for $1.63 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests and becomes exercisable on the earlier of (i) June 13, 2023 or (ii) one day prior to the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer through such vesting date."}],"balance_after":2342,"derivative":{"exercise_price":8.7,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":2342},"source":{"system":"sec-edgar","filing":"0001493152-23-002246","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315223002246/ownership.xml","form_type":"4"}},{"id":2048877,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-01-23T18:19:33.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":2342,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in the Merger in exchange for an employee stock option to acquire 12,500 shares of the common stock of Old Ayala for $10.35 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable."}],"balance_after":2342,"derivative":{"exercise_price":55.23,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":2342},"source":{"system":"sec-edgar","filing":"0001493152-23-002246","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315223002246/ownership.xml","form_type":"4"}},{"id":2048876,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-23T18:19:33.000Z","date":"2023-01-19","kind":"grant","acquired":true,"shares":46,"ownership":{"direct":false,"nature":"Held by Reporting Person's Son"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 250 shares of the common stock of Ayala Pharmaceuticals, Inc. (\"Old Ayala\") in the merger of Old Ayala into the Issuer (the \"Merger\"). On the day prior to the effective date of the Merger, the closing price of Old Ayala's common stock was $0.53 per share, and the closing price of the Issuer's common stock was $2.95 per share."}],"balance_after":46,"source":{"system":"sec-edgar","filing":"0001493152-23-002246","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315223002246/ownership.xml","form_type":"4"}},{"id":2074904,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-12-29T14:31:45.000Z","date":"2022-12-23","kind":"grant","acquired":true,"shares":20450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest in one year from the date of the grant, beginning on December 23, 2022, subject to the non-employee director's continued service on the Board of Directors."}],"balance_after":20450,"derivative":{"exercise_price":1.86,"expiration_date":"2032-12-22","underlying":"Common Stock","underlying_shares":20450},"source":{"system":"sec-edgar","filing":"0001493152-22-036752","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000149315222036752/ownership.xml","form_type":"4"}},{"id":2137355,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2022-10-14T18:27:02.000Z","date":"2022-10-12","kind":"exercise","acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018"}],"balance_after":0,"derivative":{"exercise_price":3.21,"expiration_date":"2022-10-31","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001628280-22-026400","document":"wf-form4_166577200797332.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828022026400/wf-form4_166577200797332.xml","form_type":"4"}},{"id":2137354,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-14T18:27:02.000Z","date":"2022-10-12","kind":"tax_withholding","acquired":false,"shares":3562,"price":7.51,"value":26750.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock opitons. These shares were witheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, common stock on October 12, 2022."}],"balance_after":767043,"source":{"system":"sec-edgar","filing":"0001628280-22-026400","document":"wf-form4_166577200797332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828022026400/wf-form4_166577200797332.xml","form_type":"4"}},{"id":2137353,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-14T18:27:02.000Z","date":"2022-10-12","kind":"exercise","acquired":true,"shares":8333,"price":3.21,"value":26748.93,"ownership":{"direct":true},"balance_after":770605,"source":{"system":"sec-edgar","filing":"0001628280-22-026400","document":"wf-form4_166577200797332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828022026400/wf-form4_166577200797332.xml","form_type":"4"}},{"id":2231317,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-15T20:15:35.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable on the earlier of (i) June 13, 2023 or (ii) one day prior to the Company's 2023 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":1.63,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-22-022562","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000089924322022562/doc4.xml","form_type":"4"}},{"id":2397814,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-14T21:50:05.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":2045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On December 16, 2021, the Board granted the Reporting Person options to purchase 20,450 shares at the exercise price of $2.89 per share. The options vest in full one year from the date of grant."}],"balance_after":20450,"derivative":{"exercise_price":2.89,"exercise_date":"2022-12-16","expiration_date":"2031-12-15","underlying":"Common Stock","underlying_shares":20450},"source":{"system":"sec-edgar","filing":"0001493152-22-004492","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000149315222004492/ownership.xml","form_type":"5"}},{"id":2520643,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-11-09T22:32:44.000Z","date":"2021-11-05","kind":"grant","acquired":true,"shares":8045,"price":10.1,"value":81254.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest over a twelve month period and are exercisable over a ten year period, with vesting to occur on November 5, 2021,  February 5, 2022, May 5, 2022 and August 5, 2022, respectively."}],"balance_after":8045,"derivative":{"exercise_price":10.1,"expiration_date":"2031-11-05","underlying":"Common Stock","underlying_shares":8045},"source":{"system":"sec-edgar","filing":"0001628280-21-022608","document":"wf-form4_163649714939624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021022608/wf-form4_163649714939624.xml","form_type":"4"}},{"id":2540019,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2021-10-19T19:39:48.000Z","date":"2021-10-15","kind":"grant","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017, respectively."}],"balance_after":0,"derivative":{"exercise_price":1.59,"expiration_date":"2021-11-01","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001628280-21-020221","document":"wf-form4_163467237424646.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021020221/wf-form4_163467237424646.xml","form_type":"4"}},{"id":2540018,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-19T19:39:48.000Z","date":"2021-10-15","kind":"tax_withholding","acquired":true,"shares":2629,"price":10.08,"value":26500.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. The shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on October 15, 2021."}],"balance_after":762272,"source":{"system":"sec-edgar","filing":"0001628280-21-020221","document":"wf-form4_163467237424646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021020221/wf-form4_163467237424646.xml","form_type":"4"}},{"id":2540017,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-19T19:39:48.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":16667,"price":1.59,"value":26500.53,"ownership":{"direct":true},"balance_after":764901,"source":{"system":"sec-edgar","filing":"0001628280-21-020221","document":"wf-form4_163467237424646.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828021020221/wf-form4_163467237424646.xml","form_type":"4"}},{"id":2669837,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-14T21:02:21.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable on the earlier of (i) June 10, 2022 or (ii) one day prior to the Company's 2022 annual meeting of shareholders, subject to the Reporting Person's continued service with the Issuer through such vesting date."}],"balance_after":12500,"derivative":{"exercise_price":10.35,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-21-023595","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000089924321023595/doc4.xml","form_type":"4"}},{"id":2802752,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-08T21:15:19.000Z","date":"2020-12-23","kind":"purchase","acquired":true,"shares":4,"price":11.56,"value":46.24,"ownership":{"direct":false,"nature":"Held by Reporting Person's son"},"balance_after":250,"source":{"system":"sec-edgar","filing":"0000899243-21-010346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000089924321010346/doc4.xml","form_type":"4"}},{"id":2802751,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-08T21:15:19.000Z","date":"2020-09-14","kind":"purchase","acquired":true,"shares":1,"price":10.7,"value":10.7,"ownership":{"direct":false,"nature":"Held by Reporting Person's son"},"balance_after":246,"source":{"system":"sec-edgar","filing":"0000899243-21-010346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000089924321010346/doc4.xml","form_type":"4"}},{"id":2802750,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-08T21:15:19.000Z","date":"2020-09-11","kind":"purchase","acquired":true,"shares":10,"price":10.07,"value":100.7,"ownership":{"direct":false,"nature":"Held by Reporting Person's son"},"balance_after":245,"source":{"system":"sec-edgar","filing":"0000899243-21-010346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000089924321010346/doc4.xml","form_type":"4"}},{"id":2802749,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-08T21:15:19.000Z","date":"2020-08-14","kind":"purchase","acquired":true,"shares":5,"price":11.07,"value":55.35,"ownership":{"direct":false,"nature":"Held by Reporting Person's son"},"balance_after":235,"source":{"system":"sec-edgar","filing":"0000899243-21-010346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000089924321010346/doc4.xml","form_type":"4"}},{"id":2802748,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-08T21:15:19.000Z","date":"2020-07-17","kind":"purchase","acquired":true,"shares":4,"price":11.86,"value":47.44,"ownership":{"direct":false,"nature":"Held by Reporting Person's son"},"balance_after":230,"source":{"system":"sec-edgar","filing":"0000899243-21-010346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000089924321010346/doc4.xml","form_type":"4"}},{"id":2802747,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-08T21:15:19.000Z","date":"2020-07-07","kind":"purchase","acquired":true,"shares":1,"price":9.6,"value":9.6,"ownership":{"direct":false,"nature":"Held by Reporting Person's son"},"balance_after":226,"source":{"system":"sec-edgar","filing":"0000899243-21-010346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000089924321010346/doc4.xml","form_type":"4"}},{"id":2802746,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-08T21:15:19.000Z","date":"2020-05-12","kind":"purchase","acquired":true,"shares":25,"price":15.02,"value":375.5,"ownership":{"direct":false,"nature":"Held by Reporting Person's son"},"balance_after":225,"source":{"system":"sec-edgar","filing":"0000899243-21-010346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000089924321010346/doc4.xml","form_type":"4"}},{"id":2802745,"issuer":{"id":108681,"kind":"organization","name":"Old Ayala, Inc","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-08T21:15:19.000Z","date":"2020-05-08","kind":"purchase","acquired":true,"shares":200,"price":15.27,"value":3054.0,"ownership":{"direct":false,"nature":"Held by Reporting Person's son"},"balance_after":200,"source":{"system":"sec-edgar","filing":"0000899243-21-010346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1277161/000089924321010346/doc4.xml","form_type":"4"}},{"id":2910898,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-11T19:12:37.000Z","date":"2020-05-20","kind":"purchase","acquired":true,"shares":10,"price":6.98,"value":69.8,"ownership":{"direct":false,"nature":"As custodian for son"},"balance_after":180,"source":{"system":"sec-edgar","filing":"0001493152-21-000724","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000149315221000724/ownership.xml","form_type":"4"}},{"id":2910897,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-11T19:12:37.000Z","date":"2020-05-13","kind":"purchase","acquired":true,"shares":70,"price":5.96,"value":417.2,"ownership":{"direct":false,"nature":"As custodian for son"},"balance_after":170,"source":{"system":"sec-edgar","filing":"0001493152-21-000724","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000149315221000724/ownership.xml","form_type":"4"}},{"id":2910896,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-11T19:12:37.000Z","date":"2020-05-12","kind":"purchase","acquired":true,"shares":90,"price":5.9,"value":531.0,"ownership":{"direct":false,"nature":"As custodian for son"},"balance_after":100,"source":{"system":"sec-edgar","filing":"0001493152-21-000724","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000149315221000724/ownership.xml","form_type":"4"}},{"id":2910895,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-11T19:12:37.000Z","date":"2020-05-07","kind":"purchase","acquired":true,"shares":10,"price":5.42,"value":54.2,"ownership":{"direct":false,"nature":"As custodian for son"},"balance_after":10,"source":{"system":"sec-edgar","filing":"0001493152-21-000724","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000149315221000724/ownership.xml","form_type":"4"}},{"id":2950856,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2020-12-10T22:01:13.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":8333,"price":11.96,"value":99662.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on December 8, 2020,  March 8, 2021, June 8, 2021 and September 8, 2021, respectively."}],"balance_after":8333,"derivative":{"exercise_price":11.96,"expiration_date":"2025-12-08","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001628280-20-017367","document":"wf-form4_160763765892175.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020017367/wf-form4_160763765892175.xml","form_type":"4"}},{"id":2998985,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2020-10-28T18:53:37.000Z","date":"2020-10-16","kind":"exercise","acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 2, 2015, February 2, 2016, May 2, 2016 and August 2, 2016, respectively."}],"balance_after":0,"derivative":{"exercise_price":5.46,"expiration_date":"2020-11-02","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001628280-20-014963","document":"wf-form4_160391120277763.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020014963/wf-form4_160391120277763.xml","form_type":"4"}},{"id":2998984,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-28T18:53:37.000Z","date":"2020-10-16","kind":"tax_withholding","acquired":false,"shares":10100,"price":9.01,"value":91001.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. The shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on October 16, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. The shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on October 16, 2020."}],"balance_after":748234,"source":{"system":"sec-edgar","filing":"0001628280-20-014963","document":"wf-form4_160391120277763.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020014963/wf-form4_160391120277763.xml","form_type":"4"}},{"id":2998983,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-28T18:53:37.000Z","date":"2020-10-16","kind":"exercise","acquired":true,"shares":16667,"price":5.46,"value":91001.82,"ownership":{"direct":true},"balance_after":758334,"source":{"system":"sec-edgar","filing":"0001628280-20-014963","document":"wf-form4_160391120277763.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828020014963/wf-form4_160391120277763.xml","form_type":"4"}},{"id":3161712,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2020-05-05T16:00:30.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award relates to an incentive grant awarded by the Compensation Committee and is subject to the terms of our 2015 Incentive Plan. The award vests one-third on May 4, 2021, one-third on May 4, 2022, and will be fully vested on May 4, 2023."}],"balance_after":13000,"derivative":{"exercise_price":0.66,"expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001493152-20-007726","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315220007726/ownership.xml","form_type":"4"}},{"id":3199290,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-03-20T21:07:38.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest in equal quarterly installments over a two-year period, beginning on March 31, 2020, subject to the non-employee director's continued service on the Board of Directors."}],"balance_after":12500,"derivative":{"exercise_price":2.99,"expiration_date":"2020-03-19","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001062993-20-001448","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000106299320001448/form4.xml","form_type":"4"}},{"id":3309479,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-16T21:36:31.000Z","date":"2019-12-17","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest on the one year anniversary of the date of grant, subject to the non-employee director's continued service on the Board of Directors."}],"balance_after":12500,"derivative":{"exercise_price":2.99,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001062993-20-000217","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000106299320000217/form4.xml","form_type":"4"}},{"id":3379382,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2019-11-06T22:17:42.000Z","date":"2019-11-04","kind":"grant","acquired":true,"shares":8333,"price":5.43,"value":45248.19,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 4, 2019, February 4, 2020, May 4, 2020 and August 4, 2020, respectively."}],"balance_after":8333,"derivative":{"exercise_price":5.43,"expiration_date":"2024-11-03","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001628280-19-013532","document":"wf-form4_157307864706639.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828019013532/wf-form4_157307864706639.xml","form_type":"4"}},{"id":3387895,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2019-10-25T16:30:56.000Z","date":"2019-10-24","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award relates to the annual long term incentive grant awarded by the Compensation Committee following the completion of our 2019 Fiscal Year and is subject to the terms of our 2015 Incentive Plan. The award vests one-third on October 24, 2020, one-third on October 24, 2021, and will be fully vested on October 24, 2022."}],"balance_after":10000,"derivative":{"exercise_price":0.31,"exercise_date":"2020-10-24","expiration_date":"2029-10-24","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-19-016009","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315219016009/ownership.xml","form_type":"4"}},{"id":3612155,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-03-05T23:47:19.000Z","date":"2016-12-09","kind":"grant","acquired":true,"shares":41667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents post-reverse stock split share amounts."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These non-plan options were awarded to purchase shares of common stock of the Issuer and vested in equal quarterly installments over a two-year period from the award date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents post-reverse stock split share amounts."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents post-reverse stock split share amounts."}],"balance_after":41667,"derivative":{"exercise_price":4.8,"expiration_date":"2026-12-09","underlying":"Common Stock","underlying_shares":41667},"source":{"system":"sec-edgar","filing":"0001062993-19-001146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000106299319001146/form4.xml","form_type":"4"}},{"id":3771718,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2018-11-07T17:00:31.000Z","date":"2018-11-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award relates to the annual long term incentive grant awarded by the Compensation Committee following the completion of our 2018 Fiscal Year and is subject to the terms of our 2015 Incentive Plan. The award vests one-third on November 5, 2019, one-third on November 5, 2020, and will be fully vested on November 5, 2021."}],"balance_after":30000,"derivative":{"exercise_price":0.54,"exercise_date":"2019-11-05","expiration_date":"2028-11-05","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-18-015364","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218015364/form4.xml","form_type":"4"}},{"id":3774099,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-11-05T21:16:35.000Z","date":"2018-10-22","kind":"grant","acquired":true,"shares":29200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest on the one year anniversary of the date of grant, subject to the non-employee director's continued service on the Board of Directors."}],"balance_after":29200,"derivative":{"exercise_price":5.99,"expiration_date":"2028-10-22","underlying":"Common Stock","underlying_shares":29200},"source":{"system":"sec-edgar","filing":"0001062993-18-004363","document":"form4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000106299318004363/form4a.xml","form_type":"4/A","original_submission_date":"2018-10-25"}},{"id":3774934,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase Common Stock","published_at":"2018-11-05T16:38:07.000Z","date":"2018-11-01","kind":"grant","acquired":true,"shares":8333,"price":12.73,"value":106079.09,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2018, February 1, 2019, May 1, 2019 and August 1, 2019, respectively."}],"balance_after":8333,"derivative":{"exercise_price":12.73,"expiration_date":"2023-11-01","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001628280-18-013555","document":"wf-form4_154143587133148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000162828018013555/wf-form4_154143587133148.xml","form_type":"4"}},{"id":3782898,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-10-26T01:37:30.000Z","date":"2018-10-22","kind":"grant","acquired":true,"shares":29200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest on the one year anniversary of the date of grant, subject to the non-employee director's continued service on the Board of Directors."}],"balance_after":29200,"derivative":{"exercise_price":5.99,"expiration_date":"2023-07-16","underlying":"Common Stock","underlying_shares":29200},"source":{"system":"sec-edgar","filing":"0001062993-18-004212","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000106299318004212/form4.xml","form_type":"4"}},{"id":3782897,"issuer":{"id":81814,"kind":"organization","name":"Orgenesis Inc.","symbol":"ORGS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-10-26T01:37:17.000Z","date":"2013-07-16","kind":"grant","acquired":true,"shares":20834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents post-reverse stock split share amounts."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were awarded under the Issuer's 2012 Equity Incentive Plan to purchase shares of common stock of the Issuer and vested over a period of 5 years, with 20% of the award vesting at the end of each successive anniversary of the award date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents post-reverse stock split share amounts."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents post-reverse stock split share amounts."}],"balance_after":20834,"derivative":{"exercise_price":9,"expiration_date":"2023-07-16","underlying":"Common Stock","underlying_shares":20834},"source":{"system":"sec-edgar","filing":"0001062993-18-004211","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1460602/000106299318004211/form4.xml","form_type":"4"}},{"id":3882489,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-06-27T17:15:56.000Z","date":"2018-06-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded as compensation for services on the Executive Committee of the Board of Directors."}],"balance_after":110355,"source":{"system":"sec-edgar","filing":"0001493152-18-009309","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218009309/form4.xml","form_type":"4"}},{"id":3894301,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-06-14T16:30:20.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":5000,"price":1.71,"value":8550.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a voluntary at market stock purchase by the reporting person on the open market."}],"balance_after":95355,"source":{"system":"sec-edgar","filing":"0001493152-18-008680","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218008680/form4.xml","form_type":"4"}},{"id":3895692,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-06-13T18:36:07.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":6802,"price":1.84,"value":12515.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a voluntary at market stock purchase by the reporting person on the open market."}],"balance_after":90355,"source":{"system":"sec-edgar","filing":"0001493152-18-008630","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218008630/form4.xml","form_type":"4"}},{"id":3895691,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-06-13T18:36:07.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":3198,"price":1.85,"value":5916.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a voluntary at market stock purchase by the reporting person on the open market."}],"balance_after":83553,"source":{"system":"sec-edgar","filing":"0001493152-18-008630","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315218008630/form4.xml","form_type":"4"}},{"id":4171592,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2017-11-06T18:00:24.000Z","date":"2017-11-02","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award relates to the annual long term incentive grant awarded by the Compensation Committee following the completion of our 2017 Fiscal Year and is subject to the terms of our 2015 Incentive Plan. The award fully vests on November 2, 2018."}],"balance_after":30000,"derivative":{"exercise_price":3.19,"exercise_date":"2018-11-02","expiration_date":"2027-11-02","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-17-012497","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315217012497/form4.xml","form_type":"4"}},{"id":4565526,"issuer":{"id":93434,"kind":"organization","name":"Ayala Pharmaceuticals, Inc.","symbol":"ADXS"},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option","published_at":"2016-11-07T16:32:09.000Z","date":"2016-11-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award relates to an annual grant awarded by the Compensation Committee following the completion of our 2016 Fiscal Year and is subject to the terms of our 2015 Incentive Plan. The award vests one-third on November 3, 2017, one-third on November 3, 2018, and will be fully vested on November 3, 2019."}],"balance_after":30000,"derivative":{"exercise_price":7.71,"exercise_date":"2017-11-03","expiration_date":"2026-11-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-16-014583","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100397/000149315216014583/form4.xml","form_type":"4"}},{"id":4568730,"issuer":{"id":7013,"kind":"organization","name":"CHAMPIONS ONCOLOGY, INC."},"owners":[{"id":56595,"kind":"person","name":"SIDRANSKY DAVID","position":1,"cik":"0001277161","reported_name":"SIDRANSKY DAVID","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2016-11-03T18:31:58.000Z","date":"2016-11-01","kind":"grant","acquired":true,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017, respectively."}],"balance_after":16667,"derivative":{"exercise_price":1.59,"expiration_date":"2021-10-31","underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001144204-16-131342","document":"v452159_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/771856/000114420416131342/v452159_4.xml","form_type":"4"}}]}